Stage-dependent association of BDNF and TGF-beta1 with lung function in stable COPD
Open Access
- 1 January 2012
- journal article
- Published by Springer Nature in Respiratory Research
- Vol. 13 (1) , 116
Abstract
Chronic Obstructive Pulmonary Disease (COPD) is characterised by complex inflammatory, neuronal and fibrotic changes. Brain-derived Neurotrophic Factor (BDNF) is a key regulator of neuronal plasticity, whereas Transforming Growth Factor-β1 (TGF-β1) plays a crucial role in tissue repair and emphysema pathogenesis. Both mediators are stored in platelets and released from platelets in inflammatory conditions and during serum preparation. In patients with asthma, it was previously shown that elevated serum BDNF concentrations correlate with disease severity, whereas TGF-β1 concentrations were normal.Keywords
This publication has 38 references indexed in Scilit:
- Brain‐derived neurotrophic factor induces proliferation of human airway smooth muscle cellsJournal of Cellular and Molecular Medicine, 2012
- Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary diseaseRespiratory Research, 2012
- Treating the Systemic Effects of Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2011
- Update on the roles of distal airways in COPDEuropean Respiratory Review, 2011
- Remodeling in asthma and COPD – differences and similaritiesThe Clinical Respiratory Journal, 2010
- Epidemiology of COPDEuropean Respiratory Review, 2009
- Immunologic Aspects of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2009
- Platelet and plasma BDNF in lower respiratory tract infections of the adultRespiratory Medicine, 2007
- Profiling serum biomarkers in patients with COPD: associations with clinical parametersThorax, 2007
- Brain-derived Neurotrophic Factor in Platelets and Airflow Limitation in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2005